What is cagrisema and how does it work for weight loss? Game changing' data: New obesity drugs tied to major weight loss, may reduce CV risk In Chinese adults with overweight or obesity, once weekly #GLP glucagon agonist mazdutide, at a dose of 4 mg or 6 mg for 32 48 weeks, led to clinically relevant #weightloss in the Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Current Obesity Reports Springer Nature Link What is the pipeline for future medications for obesity? International Journal of Obesity